Osteomol 665 Paracetamol

Osteomol 665 is a sustained-release pharmaceutical product containing paracetamol, specifically formulated for the management of persistent pain associated with conditions like osteoarthritis. The brand originated in Australia as a specialized high-dose formulation to provide long-lasting relief.

Ownership of the brand traditionally aligns with regional pharmaceutical distribution and manufacturing entities. Historically, the brand has been associated with various owners through acquisitions, including previous association with companies like Sanofi or regional specialists, but it is currently part of the portfolio managed by pharmaceutical groups specializing in over-the-counter and prescription pain management within the Australasian market. Manufacturing typically occurs in Australia to meet strict regulatory standards, though supply chain logistics may involve international sourcing for active ingredients.